Literature DB >> 2967889

Beta-thromboglobulin in cerebral infarction.

E Woo1, C Y Huang, V Chan, Y W Chan, Y L Yu, T K Chan.   

Abstract

Plasma beta-thromboglobulin (BTG) was significantly elevated in the acute phase of 116 atherosclerotic thrombotic (p less than 0.0001) and 36 cardioembolic (p less than 0.005) infarcts but normal for 96 lacunes compared with controls. This elevation persisted into the 6th week after the acute event. Among atherosclerotic thrombotic infarcts, the acute beta-thromboglobulin level showed a tendency to correlate with infarct size on CT and predicted mortality at 6 weeks. These results suggest that platelet aggregation plays a primary role in the pathogenesis of atherothrombosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2967889      PMCID: PMC1032974          DOI: 10.1136/jnnp.51.4.557

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Predicting the outcome of stroke: acute stage after cerebral infarction.

Authors:  J M Oxbury; R C Greenhall; K M Grainger
Journal:  Br Med J       Date:  1975-07-19

Review 2.  Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo.

Authors:  K L Kaplan; J Owen
Journal:  Blood       Date:  1981-02       Impact factor: 22.113

Review 3.  Lacunar strokes and infarcts: a review.

Authors:  C M Fisher
Journal:  Neurology       Date:  1982-08       Impact factor: 9.910

4.  Experimental cerebral ischemia produces platelet aggregates.

Authors:  J H Dougherty; D E Levy; B B Weksler
Journal:  Neurology       Date:  1979-11       Impact factor: 9.910

5.  Cardiac abnormalities in stroke patients with negative arteriograms.

Authors:  D C Good; S Frank; S Verhulst; B Sharma
Journal:  Stroke       Date:  1986 Jan-Feb       Impact factor: 7.914

6.  Usefulness of the measurement of plasma beta-thromboglobulin (beta-TG) in cerebrovascular disease.

Authors:  K Taomoto; M Asada; Y Kanazawa; S Matsumoto
Journal:  Stroke       Date:  1983 Jul-Aug       Impact factor: 7.914

7.  Prognostic value of beta-thromboglobulin in patients with transient cerebral ischaemia.

Authors:  M E Stewart; J T Douglas; G D Lowe; C R Prentice; C D Forbes
Journal:  Lancet       Date:  1983-08-27       Impact factor: 79.321

8.  Evidence for the platelet specificity of beta-thromboglobulin and studies on its plasma concentration in healthy individuals.

Authors:  C A Ludlam
Journal:  Br J Haematol       Date:  1979-02       Impact factor: 6.998

9.  Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole.

Authors:  J H Chesebro; V Fuster; L R Elveback; D C McGoon; J R Pluth; F J Puga; R B Wallace; G K Danielson; T A Orszulak; J M Piehler; H V Schaff
Journal:  Am J Cardiol       Date:  1983-05-15       Impact factor: 2.778

10.  "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.

Authors:  M G Bousser; E Eschwege; M Haguenau; J M Lefaucconnier; N Thibult; D Touboul; P J Touboul
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.